Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Abbott Atrial Fibrillation Post Approval Study

NCT05434650 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT05434650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05434650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Abbott Atrial Fibrillation Post Approval Study
Lead sponsor
Abbott Medical Devices
Phase
Observational
Overall status
Active, not recruiting
Start date
October 21, 2022
Completion date
November 30, 2026
Enrollment
200 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

atrial arrhythmia, atrial tachycardia, atrium; fibrillation